251 related articles for article (PubMed ID: 29288040)
1. Overexpression of ARID4B predicts poor survival in patients with hepatocellular carcinoma.
Wang R; Yu Z; Chen F; Liao C; Wang Q; Huang X
Hum Pathol; 2018 Mar; 73():114-121. PubMed ID: 29288040
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of signal sequence receptor γ predicts poor survival in patients with hepatocellular carcinoma.
Huang S; Zhong W; Shi Z; Wang K; Jin H; Zhang Z; Wang H; Wei Y; Chen S; Zhou Q; He X
Hum Pathol; 2018 Nov; 81():47-54. PubMed ID: 29940286
[TBL] [Abstract][Full Text] [Related]
3. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD
World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-7 downregulates the oncogene VDAC1 to influence hepatocellular carcinoma proliferation and metastasis.
Wang F; Qiang Y; Zhu L; Jiang Y; Wang Y; Shao X; Yin L; Chen J; Chen Z
Tumour Biol; 2016 Aug; 37(8):10235-46. PubMed ID: 26831666
[TBL] [Abstract][Full Text] [Related]
5. Elevated DSN1 expression is associated with poor survival in patients with hepatocellular carcinoma.
Sun C; Huang S; Ju W; Hou Y; Wang Z; Liu Y; Wu L; He X
Hum Pathol; 2018 Nov; 81():113-120. PubMed ID: 30136646
[TBL] [Abstract][Full Text] [Related]
6. ITPKA expression is a novel prognostic factor in hepatocellular carcinoma.
Li J; Zhu YH; Huang P; Zhang B; Sun J; Guan XY
Diagn Pathol; 2015 Aug; 10():136. PubMed ID: 26249031
[TBL] [Abstract][Full Text] [Related]
7. SESN2 correlates with advantageous prognosis in hepatocellular carcinoma.
Chen S; Yan W; Lang W; Yu J; Xu L; Xu X; Liu Y; Bao H
Diagn Pathol; 2017 Jan; 12(1):13. PubMed ID: 28118855
[TBL] [Abstract][Full Text] [Related]
8. High expression of myofibrillogenesis regulator-1 predicts poor prognosis for patients with hepatocellular carcinoma after curative hepatectomy.
Wang C; Xiang H; Si H; Guo D; Sun M
Int J Clin Exp Pathol; 2015; 8(11):14818-23. PubMed ID: 26823810
[TBL] [Abstract][Full Text] [Related]
9. Association of Low Zinc Finger Antiviral Protein Expression with Progression and Poor Survival of Patients with Hepatocellular Carcinoma.
Liu Y; Hu C; Zhu WB; Xu WX; Li ZY; Lin Y; Cai J; Liang JK; Zhu X; Gao ZL; Yan GM; Peng L
Cell Physiol Biochem; 2018; 49(3):1007-1018. PubMed ID: 30196292
[TBL] [Abstract][Full Text] [Related]
10. The clinical utility of the proliferating cell nuclear antigen expression in patients with hepatocellular carcinoma.
Ma S; Yang J; Li J; Song J
Tumour Biol; 2016 Jun; 37(6):7405-12. PubMed ID: 26676639
[TBL] [Abstract][Full Text] [Related]
11. H2.0-like homeobox 1 acts as a tumor suppressor in hepatocellular carcinoma.
Liu T; Chen J; Xiao S; Lei X
Tumour Biol; 2016 May; 37(5):6419-28. PubMed ID: 26631039
[TBL] [Abstract][Full Text] [Related]
12. Expression features of SOX9 associate with tumor progression and poor prognosis of hepatocellular carcinoma.
Guo X; Xiong L; Sun T; Peng R; Zou L; Zhu H; Zhang J; Li H; Zhao J
Diagn Pathol; 2012 Apr; 7():44. PubMed ID: 22515642
[TBL] [Abstract][Full Text] [Related]
13. MEP1A contributes to tumor progression and predicts poor clinical outcome in human hepatocellular carcinoma.
OuYang HY; Xu J; Luo J; Zou RH; Chen K; Le Y; Zhang YF; Wei W; Guo RP; Shi M
Hepatology; 2016 Apr; 63(4):1227-39. PubMed ID: 26660154
[TBL] [Abstract][Full Text] [Related]
14. Expression of Kindlin-1 in human hepatocellular carcinoma and its prognostic significance.
Ma HX; Shu QH; Pan JJ; Liu D; Xu GL; Li JS; Ma JL; Jia WD; Yv JH; Ge YS
Tumour Biol; 2015 Jun; 36(6):4235-41. PubMed ID: 25592379
[TBL] [Abstract][Full Text] [Related]
15. NEK2 serves as a prognostic biomarker for hepatocellular carcinoma.
Li G; Zhong Y; Shen Q; Zhou Y; Deng X; Li C; Chen J; Zhou Y; He M
Int J Oncol; 2017 Feb; 50(2):405-413. PubMed ID: 28101574
[TBL] [Abstract][Full Text] [Related]
16. Canopy Homolog 2 Expression Predicts Poor Prognosis in Hepatocellular Carcinoma with Tumor Hemorrhage.
Wang D; Wang ZM; Zhang S; Wu HJ; Tao YM
Cell Physiol Biochem; 2018; 50(6):2017-2028. PubMed ID: 30415246
[TBL] [Abstract][Full Text] [Related]
17. Prognostic implication of NQO1 overexpression in hepatocellular carcinoma.
Lin L; Sun J; Tan Y; Li Z; Kong F; Shen Y; Liu C; Chen L
Hum Pathol; 2017 Nov; 69():31-37. PubMed ID: 28964792
[TBL] [Abstract][Full Text] [Related]
18. Down-regulation of the tumour suppressor κ-opioid receptor predicts poor prognosis in hepatocellular carcinoma patients.
Chen D; Chen Y; Yan Y; Pan J; Xing W; Li Q; Zeng W
BMC Cancer; 2017 Aug; 17(1):553. PubMed ID: 28821282
[TBL] [Abstract][Full Text] [Related]
19. Growth arrest DNA damage-inducible gene 45 gamma expression as a prognostic and predictive biomarker in hepatocellular carcinoma.
Ou DL; Shyue SK; Lin LI; Feng ZR; Liou JY; Fan HH; Lee BS; Hsu C; Cheng AL
Oncotarget; 2015 Sep; 6(29):27953-65. PubMed ID: 26172295
[TBL] [Abstract][Full Text] [Related]
20. Elevated expression of Cripto-1 correlates with poor prognosis in hepatocellular carcinoma.
Wang JH; Wei W; Xu J; Guo ZX; Xiao CZ; Zhang YF; Jian PE; Wu XL; Shi M; Guo RP
Oncotarget; 2015 Oct; 6(33):35116-28. PubMed ID: 26375669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
